Literature DB >> 15666093

The transcription factor profile of human mast cells in comparison with monocytes and granulocytes.

M Babina1, Y Schülke, L Kirchhof, S Guhl, R Franke, S Böhm, T Zuberbier, B M Henz, A F Gombart.   

Abstract

Expression profiles of mRNAs and proteins for various transcription factors were determined for human skin mast cells (sMCs), leukemic HMC-1 MCs, monocytes and granulocytes. By quantitative RT-PCR, sMCs expressed lower levels of c-fos, PU.1, C/EBPalpha, and C/EBPepsilon than monocytes and granulocytes, but higher levels of MITF, SCL, GATA-1 and GATA-2. At the protein level, MITF, SCL, GATA-2, Elf-1 and c-fos were clearly detectable in sMCs. With the exception of c-fos, these proteins were absent or expressed only slightly in monocytes and granulocytes. The expression of NF-E2p45, GATA-1, PU.1, Ets-1, C/EBPalpha and C/EBPepsilon was below the detection limit in sMCs, but detectable in other myelocytes. The high expression of SCL and GATA-2 in sMCs is reminiscent of stem cells. The absence of C/EBPvarepsilon in sMCs, but strong expression in HMC-1, suggests it may impair MC maturation. In summary, mature human MCs can be characterized as C/EBPalpha(low), C/EBPvarepsilon-, PU.1(low), GATA-1(low), GATA-2+, SCL+, MITF(high).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15666093     DOI: 10.1007/s00018-004-4480-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  29 in total

1.  [Limitations of transesophageal ultrasound in the assessment of intracardiac masses: a case report].

Authors:  L Delange Segura
Journal:  Rev Esp Anestesiol Reanim       Date:  2005 Aug-Sep

Review 2.  Clinical presentation and treatment options for mitral valve myxoma.

Authors:  N Chakfé; J G Kretz; P Valentin; B Geny; H Petit; S Popescu; S Edah-Tally; G Massard
Journal:  Ann Thorac Surg       Date:  1997-09       Impact factor: 4.330

3.  Myxoma of mitral valve associated with infective endocarditis.

Authors:  R Toda; Y Moriyama; K Shiota; H Toyohira; A Taira
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-06

Review 4.  Intracardiac masses detected by echocardiography: case presentations and review of the literature.

Authors:  A Lobo; J F Lewis; C R Conti
Journal:  Clin Cardiol       Date:  2000-09       Impact factor: 2.882

5.  Atrial myxomas and thrombi: comparison of imaging features on CT.

Authors:  Hans Scheffel; Stephan Baumueller; Paul Stolzmann; Sebastian Leschka; André Plass; Hatem Alkadhi; Thomas Schertler
Journal:  AJR Am J Roentgenol       Date:  2009-03       Impact factor: 3.959

6.  Resection of a heart tumor using autotransplantation.

Authors:  H H Scheld; H W Nestle; D Kling; W A Stertmann; H Langebartels; F W Hehrlein
Journal:  Thorac Cardiovasc Surg       Date:  1988-02       Impact factor: 1.827

7.  Catastrophic systemic embolization from a left atrial myxoma.

Authors:  Benjamin D Mackie; Farheen Shirazi; Matthew J Swadley; Byron R Williams; Gautam Kumar; S Tanveer Rab
Journal:  Tex Heart Inst J       Date:  2014-02

Review 8.  Getting to the heart of the matter.

Authors:  Jack M Bernstein; William Leasure; Allison Buel
Journal:  Skinmed       Date:  2007 Nov-Dec

9.  [Left atrial myxoma: a surgical emergency. Apropos of 2 cases].

Authors:  M C Malergue; J L Laurenceau; J G Dumesnil; D Desaulniers
Journal:  Arch Mal Coeur Vaiss       Date:  1977-01

Review 10.  Left atrial myxoma with an atrial septal defect: a case report and review of the literature.

Authors:  S Tsukamoto; M Shiono; Y Orime; H Hata; S Yagi; S Kimura; M Hata; A Sezai; Y Sezai
Journal:  Ann Thorac Cardiovasc Surg       Date:  1998-06       Impact factor: 1.520

View more
  7 in total

1.  KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation.

Authors:  Youl-Nam Lee; Stephanie Brandal; Pierre Noel; Erik Wentzel; Joshua T Mendell; Michael A McDevitt; Reuben Kapur; Melody Carter; Dean D Metcalfe; Clifford M Takemoto
Journal:  Blood       Date:  2011-01-27       Impact factor: 22.113

2.  Mast cell lineage diversion of T lineage precursors by the essential T cell transcription factor GATA-3.

Authors:  Tom Taghon; Mary A Yui; Ellen V Rothenberg
Journal:  Nat Immunol       Date:  2007-07-01       Impact factor: 25.606

3.  Redefinition of the human mast cell transcriptome by deep-CAGE sequencing.

Authors:  Efthymios Motakis; Sven Guhl; Yuri Ishizu; Masayoshi Itoh; Hideya Kawaji; Michiel de Hoon; Timo Lassmann; Piero Carninci; Yoshihide Hayashizaki; Torsten Zuberbier; Alistair R R Forrest; Magda Babina
Journal:  Blood       Date:  2014-03-26       Impact factor: 22.113

Review 4.  Human eosinophils and mast cells: Birds of a feather flock together.

Authors:  Piper A Robida; Pier Giorgio Puzzovio; Hadas Pahima; Francesca Levi-Schaffer; Bruce S Bochner
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

5.  Retinoic Acid Negatively Impacts Proliferation and MCTC Specific Attributes of Human Skin Derived Mast Cells, but Reinforces Allergic Stimulability.

Authors:  Magda Babina; Metin Artuc; Sven Guhl; Torsten Zuberbier
Journal:  Int J Mol Sci       Date:  2017-02-28       Impact factor: 5.923

6.  Characterization of gene expression profiles for different types of mast cells pooled from mouse stomach subregions by an RNA amplification method.

Authors:  Soken Tsuchiya; Yuki Tachida; Eri Segi-Nishida; Yasushi Okuno; Shigero Tamba; Gozoh Tsujimoto; Satoshi Tanaka; Yukihiko Sugimoto
Journal:  BMC Genomics       Date:  2009-01-20       Impact factor: 3.969

7.  Transcription factor network downstream of protease activated receptors (PARs) modulating mouse bladder inflammation.

Authors:  Ricardo Saban; Cindy Simpson; Carole A Davis; Igor Dozmorov; Julie Maier; Ben Fowler; Michael A Ihnat; Robert E Hurst; Barry K Wershil; Marcia R Saban
Journal:  BMC Immunol       Date:  2007-08-17       Impact factor: 3.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.